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Abstract
Background: Recent advances in characterizing the immune recovery of HIV-1-infected people
have highlighted the importance of the thymus for peripheral T-cell diversity and function. The aim
of this study was to investigate differences in immune reconstitution profiles after highly active
antiretroviral therapy (HAART) between HIV-children and adults.
Methods: HIV patients were grouped according to their previous clinical and immunological
status: 9 HIV-Reconstituting-adults (HIV-Rec-adults) and 10 HIV-Reconstituting-children (HIV-Rec-
children) on HAART with viral load (VL) ≤400 copies/ml and CD4+ ≥500 cells/µL at least during 6
months before the study and CD4+ ≤300 cells/µL anytime before. Fifteen healthy-adults and 20
healthy-children (control subjects) were used to calculate Z-score values to unify value scales
between children and adults to make them comparable.
Results:  HIV-Rec-children had higher T-cell receptor excision circles (TREC) and lower
interleukin (IL)-7 levels than HIV-Rec-adults (p < 0.05). When we analyzed Z-score values, HIV-
Rec-children had higher TREC Z-score levels (p = 0.03) than HIV-Rec-adults but similar IL-7 Z-
score levels. Regarding T-cell subsets, HIV-Rec-children had higher naïve CD4+ (CD4+CD45RA
hi+CD27+), naïve CD8+ (CD8+CD45RA hi+CD27+), and memory CD8+ (CD8+CD45RO+) cells/µl
than HIV-Rec-adults, but similar memory CD4+ (CD4+CD45RO+) counts. HIV-Rec-children had
lower naïve CD8+ Z-score values than HIV-Rec-adults (p = 0.05).
Conclusion: Our data suggest that HIV-Rec-children had better thymic function than HIV-Rec-
adults and this fact affects the peripheral T-cell subsets. Thus, T-cell recovery after HAART in HIV-
Rec-adults could be the consequence of antigen-independent peripheral T-cell expansion while in
HIV-Rec-children thymic output could play a predominant role in immune reconstitution.
Background
Dysfunction of the immune system is evident in human
immunodeficiency virus (HIV)-patients, even from the
early phase of the HIV infection. The highly active antiret-
roviral therapy (HAART) dramatically affects the course of
HIV-infection [1,2], because it induces a significant
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immunological improvement associated with suppres-
sion of viral load (VL) [3,4]. Most of HIV-patients on
HAART are able to recover "normal" CD4+ T-cell counts
(>500 cells/µl), and a substantial increase in naïve CD4+
and recent thymic emigrants expressing T-cell receptor
excision circles (TREC) has been reported [5,6].
Immune recovery after HAART has been explained by
either peripheral expansion of pre-existent naïve T cells,
by recovery of new T cells derived from thymic production
or by reversion from memory (CD45RO+) to naïve
(CD45RA hi+CD27+) phenotype of peripheral T cells [7].
IL-7 is very important in CD4+ recovery because it is
implicated in thymopoiesis, peripheral T-cell expansion
and survival of T cells. [8]. We carried out a cross-sectional
study on HIV-patients (adults and children), who had
recovered normal CD4+  T-cell counts after HAART,
grouped according to their previous clinical and immuno-
logical status to assess the different profiles of immune
reconstitution.
Methods
Study population
We carried out a cross-sectional study on HIV-patients
(adults and children) grouped according to their previous
clinical and immunological status. HIV-children were
recruited in the Immuno-pediatric Unit (Hospital General
Universitario "Gregorio Marañón", Madrid, Spain), and
all children had been infected by vertical transmission.
HIV-adults were recruited in Internal Medicine Unit (Hos-
pital Universitario "Virgen del Rocio", Seville, Spain) with
the following risk groups: 6 Intravenous drug users, 2 Het-
erosexuals, 1 Homosexual.
HIV patients, adults and children, were selected based on
the following criteria: a) CD4+/µL greater than 500 cells/
µL; b) HIV-RNA levels below detectable limits (VL ≤400
copies/ml) at least during 6 months before the study; c)
prior diagnosis of AIDS but currently asymptomatic; d) on
HAART at least during 6 months before the study. Also,
healthy individuals (Healthy-adults and Healthy-chil-
dren) were included in the study.
This study was conducted according to the declaration of
Helsinki and approved by the Ethical Committees of all
hospitals involved. Written informed consent was
obtained from HIV-adults and the parents/guardians of
children.
Drugs were prescribed by attending physicians according
to Centers for Disease Control and Prevention (CDC)
guidelines [9]. Clinical classification was based on the
1994 revised guidelines of the CDC [10]. The analyses of
phenotypic subsets, TRECs and IL-7 quantification were
carried out in a central laboratory (Laboratorio de
Immuno-Biología Molecular, Hospital General Universi-
tario "Gregorio Marañón") using standard procedures.
Quantification of HIV-1 RNA and IL-7 in plasma
Blood samples were collected in EDTA tubes, separated
within 4 h and the plasma was stored at -70°C. Plasma VL
was quantified by Amplicor standard assay (Amplicor
monitor, Roche Diagnostic Systems, Brandenburg, NJ,
USA). Quantification of IL-7 levels was performed in
duplicate using a ELISA assay kit (Quantikine HS IL-7 kit;
R&D Systems, Abingdon, UK) [5].
Quantification of lymphocyte subsets
Lymphocyte subsets were analyzed by four-color multi-
parametric flow cytometry. First, the blood was lysed with
ImmunoPrep™ Reagent System (Beckman-Coulter, Inc;
Fullerton, CA, USA) in a Coulter® TQ-Prep™ Workstation
(Coulter Corporation, Miami, FL, USA). Then, the lym-
phocyte acquisition was carried out in a COULTER®
EPICS®  XL™ Flow Cytometer from Beckman-Coulter
(Coulter Corporation) using the EXPO™32 ADC Software
(Coulter Corporation) acquisition program immediately
after cell staining [11]. Data were analyzed using the
EXPO™32 ADC Software (Coulter Corporation) program.
CYTO-COMP®  cell kit, CYTO-COMP®  reagent kit, and
IMMUNOTROL® were routinely used as quality controls.
The monoclonal antibodies used for the analyses of lym-
phocyte subsets were conjugated with Fluorescein-isothy-
ocyanate (FITC) (anti-CD45, anti-CD45RA), Phycoerytrin
(PE) (anti-CD27, anti-CD4), Phycoerytrin-Texas Red®-x
(ECD) (anti-CD8), and R-Phycoerytrin-cyanin 5.1 (PC5)
(anti-CD3, anti-CD4, anti-CD8). Anti-CD27-FITC, anti-
CD4-PC5, and anti-CD8-PC5 were obtained from Immu-
notech (Marseille, France), and anti-CD45RA-PE from
Southern Biotechnology Associates (Birmingham, AL,
USA). The rest of the monoclonal antibodies were
obtained from Cyto-Stat® Tetra-chrome™ (Coulter Corpo-
ration).
Quantification of TCR rearrangement excision circles
Thymic function was studied by quantifying the produc-
tion of TRECs in peripheral blood mononuclear cells
(PBMC) by real-time quantitative PCR in a LightCycler
system (Roche Molecular Biochemicals, Mannheim, Ger-
many) [5]. Samples were analyzed in triplicate and they
never varied more than 10%. A β-globin control PCR was
performed to verify the presence of the same content of
DNA in all samples.
Statistical analysis
The immunological values of HIV-adults and HIV-chil-
dren (Xi) were transformed to Z-scores (Z  -  score  =
) using the mean ( ) and standard deviation
Xi - X ()
σ
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(σ) of Healthy-adults and Healthy-children respectively to
unify value scales between children and adults to make
them comparable. We calculated the differences between
groups using the Mann-Whitney test.
Results
Characteristics of HIV-1-infected patients
The HIV-patients were 9 HIV-Rec-adults (median (min;
max): 40.8 (34.6; 43.7) years) and 10 HIV-Rec-children
(median (min; max): 9.5 (7.1; 16.8) years) on HAART
who had viral load (VL) ≤400 copies/ml and CD4+ ≥500
cells/µL at least 6 months prior to the study. Moreover, all
patients had CD4+ ≤300 cells/µL and a diagnosis of AIDS
at some point. These patients were compared with 15
Healthy-adults (median (min; max): 28.2 (26.3; 36.5)
years) and 20 Healthy-children (median (min; max): 11.4
(6.3; 17.6) years). At the time of the study, HIV-Rec-adults
and HIV-Rec-children had VL ≤400 copies/ml.
Markers of immune reconstitution
HIV-Rec-children had lower CD4+ counts (absolute and
percentage) and higher %CD8+ than Healthy-control, but
HIV-Rec-adults had no statistical differences in CD4+
absolute counts (Table 1). HIV-Rec-children did not have
higher CD4+ absolute counts than HIV-Rec-adults (p =
0.072). However, when we analyzed the Z-score values,
startlingly, we found that HIV-Rec-children had lower
CD4+/µl Z-score values than HIV-Rec-adults (Table 2).
Table 1: Summary of immunological parameters of HIV patients and HIV-seronegative individuals for the cross-sectional study.
HIV-Rec-adults Healthy-adults (a)p HIV-Rec-children Healthy-children (b)p (c)p
No. of subjects 91 5 1 0 2 0
T cells
CD4+ (%) 33.7 (25.9; 42.3) 42 (29.3; 56.6) 0.035 30.5 (18.1; 39.98) 42.3 (29.5; 55.4) 0.001 0.193
CD8+ (%) 36.2 (25.7; 53.5) 22.7 (16.1; 32.3) <0.001 38.6 (24.1; 63.9) 22.3 (13.6; 28.1) <0.001 1
CD4+/µl 675 (563; 922) 864 (524; 1265) 0.815 837.5 (631; 1111) 1288 (588; 2804) 0.016 0.072
CD8+/µl 881 (632; 1765) 492 (196; 878) <0.001 1038.5 (444; 2726) 673 (304; 1641) 0.091 0.620
Thymic function
TRECs/105 PBMC 25 (10; 106) 247 (10; 865) 0.006 10186 (1430; 18026) 16097 (5944; 43620) 0.082 <0.001
IL-7 (pg/ml) 5.5 (2.9; 11.2) 4.3 (2.4; 7.5) 0.015 2.2 (0.8; 7.14) 0.6 (0.3; 1.8) 0.001 0.002
Values are expressed as median (minimum; maximum). TREC: TCR rearrangement excision circles. Differences were calculated by U-test of Mann-
Whitney.
(a): p-values between HIV-Rec-adults and Healthy-adults.
(b): p-values between HIV-Rec-children and Healthy-children.
(c): p-values between HIV-Rec-adults and HIV-Rec-children.
Table 2: Summary of Z-scores of immunological markers in HIV patients for the cross-sectional study.
HIV-Rec-adults HIV-Rec-children p
T cells
CD4+ (%) -0.83 (-2.29; -0.01) -1.56 (-3.32; -0.24) 0.079
CD8+ (%) 2.03 (0.53; 5.62) 3.99 (0.38; 10.28) 0.497
CD4+/µl -0.05 (-0.61; 0.43) -0.88 (-1.2; -0.47) <0.001
CD8+/µl 2.12 (0.81; 7.54) 0.75 (-0.93; 5.5) 0.053
Thymic function
TRECs/105 PBMC -1.10 (-1.15; -0.83) -0.74 (-1.43; -0.12) 0.036
IL-7 (pg/ml) 0.73 (-1.05; 4.62) 2.71 (-0.06; 12.8) 0.356
T-cell subsets (%)
CD4+CD45RAhi+CD27+ -0.39 (-2.07; 0.7) -0.61 (-3.17; 0.48) 0.400
CD8+CD45RAhi+CD27+ -1.36 (-2.52; -0.25) -2.52 (-4.63; 0.02) 0.053
CD4+CD45RO+ 0.95 (-1.1; 3.92) 0.06 (-2.08; 5.55) 0.243
CD8+CD45RO+ 1.48 (-0.38; 6.42) 2.43 (-0.28; 5.89) 0.780
T-cell subsets/µl
CD4+CD45RAhi+CD27+ -0.34 (-1.42; 0.62) -0.89 (-1.23; -0.39) 0.243
CD8+CD45RAhi+CD27+ -0.45 (-0.9; 1.38) -0.49 (-1.09; 0.92) 0.842
CD4+CD45RO+ -0.03 (-0.64; 0.52) -0.54 (-1.1; 0.97) 0.095
CD8+CD45RO+ 2.58 (0.61; 12.8) 1.01 (-0.5; 10.39) 0.315
Values are expressed as median (minimum; maximum). Differences were calculated by U-test of Mann-Whitney. p: p-values between HIV-Rec-
adults and HIV-Rec-children.BMC Infectious Diseases 2006, 6:112 http://www.biomedcentral.com/1471-2334/6/112
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Interestingly, HIV-Rec-adults had lower TREC values and
higher IL-7 levels than healthy-adults, but HIV-Rec-chil-
dren had similar TREC values and higher IL-7 levels than
healthy-children (Table 1). Moreover, we observed that
HIV-Rec-children had higher TREC and lower IL-7 levels
than HIV-Rec-adults (Table 1). When we compared the Z-
score values of HIV-Rec-adults and HIV-Rec-children, we
found that HIV-Rec-children had similar IL-7 and higher
TREC Z-score values than HIV-Rec-adults (Table 2).
HIV-patients had similar naïve %CD4+ and lower naïve
%CD8+ than Healthy-controls (Table 3). However, when
we analyzed the absolute counts, we found that HIV-Rec-
children had lower naïve CD4+ than Healthy-control but
similar naïve CD8+. Moreover, HIV-Rec-children had
higher naïve CD4+ percentages and absolute counts, and
higher naïve CD8+ absolute counts than HIV-Rec-adults,
but similar naïve CD8+percentages (Table 3).
Regarding memory subsets, overall, HIV-patients had sim-
ilar memory CD4+ counts as Healthy-control; but when
we analyzed memory CD8+, we found that HIV-patients
had higher counts than Healthy-control (Table 3). Fur-
thermore, HIV-Rec-children had similar memory CD4+
percentage and absolute counts, similar memory CD8+
percentage and higher memory CD8+ absolute counts
than HIV-Rec-adults (Table 3). Moreover, HIV-Rec-chil-
dren had lower naïve CD8+ Z-score values than HIV-Rec-
adults (p = 0.055).
Discussion
In humans, it is well established that HIV-1 infection
adversely affects the thymus in both children and adults
[7,12]. However, a recent study showed that long term
survivors of paediatric HIV infection appear to have
retained or recovered thymic volume and thymic activity
approximating uninfected youths [13]. Yet the conse-
quences of this thymic inhibition are worse in children,
which has been proposed as one cause of the rapid pro-
gression of the disease [14-16]. Early ART in HIV-infected
children has proven to induce an early immune reconsti-
tution that correlates with the increase in thymus volume
[17]. ART has also proven to be effective in recovering
appropriate CD4+ levels in HIV-infected patients with low
CD4+ counts [5,18-21], possibly through the production
of new T cells in the thymus. This is particularly relevant
for children, who have a smaller T-cell pool and thus rely
more heavily upon thymic output for the generation of
immune-competent memory T cells.
In this study, we observed that HIV-infected patients have
lower thymic production than healthy controls. This
inhibitory effect on the thymus may be due to the ability
of HIV to infect and destroy thymocytes [22]. This would
decrease the thymic production of new T cells and hinder
both the appropriate maturation of the child's immune
system and the reconstitution of cells lost due to the infec-
tion. When the thymic function of these HIV+ children on
ART is analysed by the assessment of TRECs, it can be seen
that the decrease in the viral load leads to a marked rise in
thymic function [23,24], and it correlates well with the
recovery of CD4+ T-cell population [5,6,24-26].
In this study, we analyzed, as a whole, different aspects of
immunity in HIV-1 infected patients on HAART with a
previous moderate to severe immunosuppression state
and who had been able to recover "normal" CD4+ T-cell
counts (>500 cells/µl). Interestingly, HIV-Rec-adults had
lower TREC Z-score levels than HIV-Rec-children. There-
fore, our results contribute new findings and extend the
previous data indicating that T-cell reconstitution in HIV-
adults is mainly thymus-independent [7]. However, HIV-
Rec-adults had detectable TREC levels, although lower
than healthy-adults, indicating their thymus was some-
Table 3: Summary of T-cell subsets of HIV patients and HIV-seronegative individuals for the cross-sectional study.
HIV-Rec-adults Healthy-adults (a)p HIV-Rec-children Healthy-children (b)p (c)p
T-cell subsets (%)
CD4+CD45RAhi+CD27+ 36.8 (15.57; 51.86) 45.2 (16.5; 61.1) 0.263 56.4 (30.5; 67.4) 61.9 (45.9; 77.7) 0.080 0.009
CD8+CD45RAhi+CD27+ 26.61 (9.82; 62.3) 41.5 (27.5; 76.8) 0.001 38.1 (15.3; 65.8) 68.9 (44; 82.7) 0.001 0.107
CD4+CD45RO+ 51.2 (27.8; 85) 40.4 (21; 66.7) 0.048 41.2 (21; 92.5) 39.2 (24.8; 55.5) 0.683 0.243
CD8+CD45RO+ 27.4 (11.7; 69.4) 11.3 (3.4; 32.5) 0.007 52.1 (30; 80.3) 30.2 (20.4; 48.6) 0.002 0.133
T-cell subsets/µl
CD4+CD45RAhi+CD27+ 296.8 (79.1; 493.5) 279 (172; 868.3) 0.263 445 (264; 716.6) 743.4 (289; 2062) 0.004 0.005
CD8+CD45RAhi+CD27+ 172.6 (96.8; 519.5) 164.1 (94; 524.4) 0.861 390 (225; 777.4) 463 (156; 1005) 0.495 0.002
CD4+CD45RO+ 351.8 (238.5; 453.6) 298.5 (171; 833.8) 0.682 374.8 (182.8; 894.8) 515.4 (151; 1368.6) 0.203 0.780
CD8+CD45RO+ 184.2 (96.4; 640.2) 64.3 (18; 162.7) <0.001 413.5 (153.; 2019.1) 183.7 (67; 691.6) 0.006 0.043
Values are expressed as median (minimum; maximum). Differences were calculated by U-test of Mann-Whitney.
(a): p-values between HIV-Rec-adults and Healthy-adults.
(b): p-values between HIV-Rec-children and Healthy-children.
(c): p-values between HIV-Rec-adults and HIV-Rec-children.BMC Infectious Diseases 2006, 6:112 http://www.biomedcentral.com/1471-2334/6/112
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what functional [11,27]. In addition, HIV-adults had
naïve CD4+ and CD8+ counts too high to be explained by
the low TREC values observed in peripheral blood. The
HIV-adults could still have a defective immune system
despite normal recovery of CD4+ counts, although we can-
not determine this since we do not have data on their TCR
repertoire. Furthermore, HIV-children had a mainly thy-
mus-dependent immune reconstitution [5,28]. Thymic
function of HIV-Rec-children had a greater capacity for
recovery during severe HIV-infection, and they seemed to
be less affected than the HIV-Rec-adults when TREC Z-
score values were compared.
Interestingly, HIV-infected patients have abnormally high
plasma levels of IL-7 associated with low counts of CD4+
[29]. This suggests that low CD4+ counts should stimulate
peripheral dendritic cells and lymphatic ganglia to pro-
duce IL-7, in an attempt to activate the mechanisms that
allow cell repopulation [29]. By contrast, other studies
have suggested that plasma IL-7 levels may simply reflect
the dynamics of binding secreted IL-7 to T cells: the fewer
circulating T cells, the greater amount of free IL-7 [30].
However, these high levels of IL-7 are ineffective in adults
since no increase in thymic production or recuperation of
the CD4+ T-cell repertoire has been observed, possibly due
to the limited ability of the adult thymus to produce new
T cells.
Thus, better thymic function in HIV-children may allow
for the maintaining of a high output of naïve T cells result-
ing in lower IL-7 levels [31]. In contrast, the thymus of
HIV-adults generated less naïve T cells, making it neces-
sary for more IL-7 to generate T cells by antigen-independ-
ent peripheral expansion [7,27]. Therefore, the high
values of IL-7 could be considered normal in HIV-adults
and their immune reconstitution via stimulation T cell
peripheral expansion may be more IL-7-dependent. How-
ever, a role of the thymus cannot be discarded in immune
reconstitution in HIV-adults.
In our experience, high levels of IL-7 in children with
lower CD4+ counts lead to a dramatic increase in the
thymic production of new T cells and a marked recovery
of CD4+ counts [5]. This increase in thymic function takes
place whenever viral load levels are low enough. Then,
with the recovery of CD4+ counts, IL-7 returns to basal
values as a consequence of a feedback mechanism [5].
Among HIV-children, we found that the thymic function
of HIV-Rec-children appears to be normal, although it is
well-known that HIV-infection could produce irreversible
injury to the thymus of HIV-patients with AIDS [7]. How-
ever, high IL-7 values in HIV-Rec-children could increase
the thymic output, increasing TRECs values and compen-
sating for the faulty thymic function. It is also possible
that IL-7 stimulates the production of T cells by antigen-
independent peripheral expansion [7]. It is unclear why
HIV-patients had a deficient de novo generation of CD4+
but not of CD8+. Extrathymic CD8+ but not CD4+ lym-
phopoiesis has been documented in mice, which if extrap-
olated to humans could partially explain those differences
[32,33]. Alternatively, this finding could be explained by
elevated peripheral proliferation of naïve CD4+ and CD8+
[34].
A limitation of the study could be that immunological
recovery was dependent on sustained VL suppression and
efficacy of antiretrovirals that contribute to the HAART
regimen. In this study, the size of groups was very small
and we could not make strata according to antiretroviral
therapy and sustained VL suppression periods to check the
possible effect of these two factors. Another limitation of
our study was that there was a difference between the age
of healthy adults of the control group and HIV-Rec-adults.
However, we think this difference has a low impact on the
TREC levels in adults, since all of the subjects were adults
inside an age range of approximately 25–40 years, Harris
et al [35] in a previous study showed that thymic abun-
dance was not inversely correlated with age in HIV-
infected adults and the variation in the 25–40 year-old
range is minimal.
Conclusion
In summary, HIV-Rec-children had better thymic function
than HIV-Rec-adults which affects the composition of
peripheral T-cell subsets. So, T-cell recovery after HAART
in HIV-Rec-adults could be the consequence of antigen-
independent peripheral expansion, while neolymphopoi-
esis in the thymus of HIV-Rec-children could play an
important role in immune reconstitution. Therefore, HIV-
patients with similar CD4+ counts could have CD4+ of dif-
ferent origins and function.
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CD4+CD45RAhi+CD27+ Naïve CD4+ T-cells
CD4+CD45RO+ Memory CD4+ T-cells
CD8+CD45RAhi+CD27+ Naïve CD8+ T-cells
CD8+CD45RO+ Memory CD8+ T-cells
CDC Centers for Disease Control and Prevention
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Healthy-children Healthy age-matched uninfected chil-
dren as controls.
HIV-Rec-adults  HIV-adults in clinical category C and
CD4+ T-cell ≤300 cells/µL anytime before who responded
to the treatment recovering CD4+ T-cell >500 cells/µL after
HAART.
HIV-Rec-children HIV-children in clinical category C and
CD4+ T-cell ≤300 cells/µL anytime before who responded
to the treatment recovering CD4+ T-cell >500 cells/µL after
HAART.
IL Interleukin
PBMC Peripheral blood mononuclear cells
TREC T-cell receptor excision circles
VL Viral load
Z-scores Z - score =   using the mean ( ), stand-
ard deviation (σ), and values of HIV-adults and HIV-chil-
dren (Xi)
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